{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:39:49Z","timestamp":1792269589138,"version":"4.4.0"},"reference-count":26,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,9,7]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Immune checkpoint inhibitor (ICI)-induced pancreatitis is a rare immune-related adverse event that can present as mass-forming lesions mimicking metastatic disease, posing a diagnostic challenge in patients with cancer. We report the case of a woman with early triple-negative breast cancer who, after 4 months of neoadjuvant chemoimmunotherapy, experienced progression of the primary tumour. Restaging PET-CT revealed four hypermetabolic pancreatic lesions, suggestive of metastases. Abdominal MRI confirmed the presence of pancreatic masses. Endoscopic ultrasound-guided biopsy revealed immune-related pancreatitis with no malignant cells. Laboratory workup showed elevated amylase and lipase levels despite the patient being asymptomatic. ICI was discontinued and corticosteroid therapy was initiated, with normalisation of pancreatic enzymes. After excluding metastatic spread, the patient underwent a total mastectomy for local progression. This case highlights that ICI-induced pancreatitis can mimic metastatic disease and that tissue biopsy is essential to avoid misdiagnosis and inappropriate treatment escalation.<\/jats:p>","DOI":"10.1136\/bcr-2026-274710","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:40:38Z","timestamp":1790239238000},"page":"e274710","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer"],"prefix":"10.1136","volume":"19","author":[{"given":"Margaux","family":"Mouchet","sequence":"first","affiliation":[{"name":"Oncology Department, Centre Hospitalier du Valais Romand, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Gourmaud","sequence":"additional","affiliation":[{"name":"Pathology Department, Institut Central des Hopitaux, Institut Central des Hopitaux, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ehab","family":"Kamel","sequence":"additional","affiliation":[{"name":"Centre Hospitalier du Valais Romand, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7555-1556","authenticated-orcid":false,"given":"Marie-Gabrielle","family":"Court\u00e8s","sequence":"additional","affiliation":[{"name":"Oncology, H\u00f4pital de Sion Centre Hospitalier du Valais Romand, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092401401482000_19.9.e274710.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409932"},{"key":"2026092401401482000_19.9.e274710.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202809"},{"key":"2026092401401482000_19.9.e274710.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166299"},{"key":"2026092401401482000_19.9.e274710.4","doi-asserted-by":"crossref","first-page":"955701","DOI":"10.3389\/fphar.2022.955701","article-title":"Pancreatic injury following immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026092401401482000_19.9.e274710.5","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1097\/MPA.0000000000002582","article-title":"Immune Checkpoint Inhibitor-Induced Pancreatic Injury: An Emerging Form of Immune-Mediated Pancreatitis","volume":"55","author":"Alsaleh","year":"2026","journal-title":"Pancreas"},{"key":"2026092401401482000_19.9.e274710.6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/PAS.0000000000002398","article-title":"Clinicopathologic Characteristics of Immune Checkpoint Inhibitor-related Pancreatitis","volume":"49","author":"Chen","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"2026092401401482000_19.9.e274710.7","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.2169\/internalmedicine.5072-24","article-title":"Immune Checkpoint Inhibitor-induced Mass-forming Pancreatitis and Lipodystrophy: A Case Report and Review of the Literature","volume":"64","author":"Oi","year":"2025","journal-title":"Intern Med"},{"key":"2026092401401482000_19.9.e274710.8","first-page":"1449","article-title":"Secondary tumors of the pancreas: a case series","volume":"32","author":"Pan","year":"2012","journal-title":"Anticancer Res"},{"key":"2026092401401482000_19.9.e274710.9","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1002\/cam4.5374","article-title":"Fine needle aspiration of pancreatic lesions focusing on secondary tumors with emphasis of metastatic breast cancer: A clinicopathological study with follow-up","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med"},{"key":"2026092401401482000_19.9.e274710.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0086-2"},{"key":"2026092401401482000_19.9.e274710.11","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-12-2","article-title":"Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment","volume":"12","author":"Molino","year":"2014","journal-title":"World J Surg Oncol"},{"key":"2026092401401482000_19.9.e274710.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1100-7"},{"key":"2026092401401482000_19.9.e274710.13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-024-01452-0","article-title":"Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis","volume":"42","author":"Luo","year":"2024","journal-title":"Invest New Drugs"},{"key":"2026092401401482000_19.9.e274710.14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.6004\/jnccn.2023.7034","article-title":"Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy","volume":"21","author":"Townsend","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2026092401401482000_19.9.e274710.15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093076","article-title":"Autoimmune Pancreatitis: A Review","volume":"14","author":"Vemulapalli","year":"2025","journal-title":"J Clin Med"},{"key":"2026092401401482000_19.9.e274710.16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00535-026-02389-2","article-title":"Immune checkpoint inhibitor-related pancreatitis: a comprehensive review of epidemiology, pathophysiology, and management","volume":"61","author":"Lee","year":"2026","journal-title":"J Gastroenterol"},{"key":"2026092401401482000_19.9.e274710.17","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.117208"},{"key":"2026092401401482000_19.9.e274710.18","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: management of immune checkpoint inhibitor-related toxicities. Version 1. 2026. Available: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1500"},{"key":"2026092401401482000_19.9.e274710.19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00535-024-02083-1","article-title":"Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy","volume":"59","author":"Nagao","year":"2024","journal-title":"J Gastroenterol"},{"key":"2026092401401482000_19.9.e274710.20","doi-asserted-by":"crossref","unstructured":"Schneider BJ , Naidoo J , Santomasso BD , et al . Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021. doi:10.1200\/JCO.21.01440","DOI":"10.1200\/JCO.21.01440"},{"key":"2026092401401482000_19.9.e274710.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645"},{"key":"2026092401401482000_19.9.e274710.22","doi-asserted-by":"crossref","first-page":"109250","DOI":"10.1016\/j.ejrad.2020.109250","article-title":"Imaging findings of immune checkpoint inhibitor associated pancreatitis","volume":"131","author":"Das","year":"2020","journal-title":"Eur J Radiol"},{"key":"2026092401401482000_19.9.e274710.23","doi-asserted-by":"crossref","unstructured":"Lu Z , Wang L , Lu P , et al . IgG4-related autoimmune pancreatitis mimicking pancreatic carcinoma: a case report. Front Med 2026;13. doi:10.3389\/fmed.2026.1866706","DOI":"10.3389\/fmed.2026.1866706"},{"key":"2026092401401482000_19.9.e274710.24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1055\/a-1183-3583","article-title":"Usefulness of endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of autoimmune pancreatitis using a 22-gauge Franseen needle: a prospective multicenter study","volume":"52","author":"Ishikawa","year":"2020","journal-title":"Endoscopy"},{"key":"2026092401401482000_19.9.e274710.25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOG.0000000000000873","article-title":"Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)","volume":"38","author":"Sayed Ahmed","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"2026092401401482000_19.9.e274710.26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5009\/gnl210241","article-title":"Type 2 Autoimmune Pancreatitis: Consensus and Controversies","volume":"16","author":"Zen","year":"2022","journal-title":"Gut Liver"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-274710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:40:42Z","timestamp":1790239242000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-274710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bcr-2026-274710"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-274710","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}